Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Nov 1.

Published in final edited form as: Leuk Res. 2018 Jul 19;74:130–136. doi: 10.1016/j.leukres.2018.07.016

Table 2:

Number of t-MN after autotransplant according to diagnosis groups and competitive events^a (n=3335)

t-MN	Subtotal N^b			Total(N)
t-MN	HL	NHL	PCM	Total(N)
AML	7	45	23	75
MDS transformed to AML^c	5	26	8	39
MDS	19	127	75	221
Total	31	198	106	335

^a

Events = relapse, unplanned 2^nd transplant, non-myeloid new malignancy

^b

Two MN cases were excluded because they were diagnosed before day 100

^c

In our analyses these are scored as MDS, so there are 39 + 221 = 260 MDS cases.